Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,303 | -3,603 | -1,708 | -7,143 | -5,623 |
| Depreciation Amortization | 832 | 558 | 279 | 1,110 | 832 |
| Accounts receivable | -11 | N/A | N/A | N/A | N/A |
| Other Working Capital | 679 | 398 | 243 | 375 | 240 |
| Other Operating Activity | 2,912 | 1,942 | 913 | 3,759 | 2,976 |
| Operating Cash Flow | $-891 | $-704 | $-274 | $-1,899 | $-1,575 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -29 | -16 |
| Investing Cash Flow | $N/A | $0 | $N/A | $-29 | $-16 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 869 | 679 | 400 | 974 | 914 |
| Common Stock Issued | N/A | N/A | N/A | 609 | 609 |
| Other Financing Activity | 70 | 0 | 0 | -22 | -22 |
| Financing Cash Flow | $939 | $679 | $400 | $1,560 | $1,500 |
| Beginning Cash Position | 90 | 90 | 90 | 458 | 458 |
| End Cash Position | 139 | 66 | 217 | 90 | 367 |
| Net Cash Flow | $48 | $-25 | $126 | $-367 | $-91 |
| Free Cash Flow | |||||
| Operating Cash Flow | -891 | -704 | -274 | -1,899 | -1,575 |
| Capital Expenditure | N/A | N/A | N/A | -29 | -16 |
| Free Cash Flow | -891 | -704 | -274 | -1,928 | -1,591 |